Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Tyrosine kinase inhibitors for endocrine tumors often cause skin issues, requiring early management and treatment adjustments.

Platelet-rich plasma doesn't prevent hair loss from chemotherapy, and mononuclear cells only help against hair loss from one specific chemotherapy drug.

CTP-543 is generally safe for treating alopecia areata.

Busulfan/cyclophosphamide and total bone irradiation are equally effective for AML transplants.

Clinicians should consider individual factors and communicate risks and benefits when prescribing ritlecitinib for adolescent alopecia areata.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Some cancer treatments cause different types of hair loss, but scalp cooling can help prevent it.

Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

M50054 may help treat hepatitis and hair loss from chemotherapy.

Nanocarriers can improve skin treatments after cancer therapy by enhancing antioxidant delivery and effectiveness.

TS-13 effectively stops tumor growth and reduces chemotherapy side effects.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

Natural honey protects against Doxorubicin's harmful effects.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

The treatment combination is safe and effective for some patients with this type of breast cancer.

Chemotherapy reduces splenic melanin in mice.

Targeting androgen receptor signaling may improve acute myeloid leukemia treatment.

PPARγ signaling modulation can protect hair follicle stem cells from chemotherapy-induced damage.

Oncologists should better understand the unique impact of hair loss on Black breast cancer patients to offer more compassionate care.

The document discusses a special exam case for formulating and using systemic therapy named Athena.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

Skin reactions from cancer treatments might predict how well the treatments work.

Targeted cancer therapies often cause skin side effects, needing dermatologist care.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

Scalp cooling and minoxidil can help manage hair loss after chemotherapy.

A woman developed severe bladder inflammation after cancer treatment with Cytoxan.

Compound 7p shows strong potential as an anticancer agent.